The role of MyD88- and TRIF-dependent signaling in monophosphoryl lipid A-induced expansion and recruitment of innate immunocytes

Journal of Leukocyte Biology

Volumn 100, Issue 6, 2016, Pages 1311-1322

  Hernandez, Antonio ^a   Bohannon, Julia K ^a   Luan, Liming ^a   Fensterheim, Benjamin A ^a   Guo, Yin ^a   Patil, Naeem K ^a   McAdams, Chase ^a   Wang, Jingbin ^a   Sherwood, Edward R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cytokines; Innate immunity; Monocyte; Myeloid progenitors; Neutrophil; TLR4

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; L SELECTIN; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHORYL LIPID A; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; CXCL1 PROTEIN, MOUSE; CXCL2 PROTEIN, MOUSE; LIPID A; MYD88 PROTEIN, MOUSE; TICAM-1 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW DERIVED MACROPHAGE; CELL ACTIVATION; CELL EXPANSION; CELL FUNCTION; CELL MOTILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; INNATE IMMUNITY; LYMPHOID CELL; MALE; MONOCYTE; MOUSE; MYELOID PROGENITOR CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN WEIGHT; UPREGULATION; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DEFICIENCY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MYELOPOIESIS; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ANTIGENS, CD11B; CHEMOKINE CXCL1; CHEMOKINE CXCL2; CHEMOTAXIS, LEUKOCYTE; GRANULOCYTE COLONY-STIMULATING FACTOR; IMMUNITY, INNATE; L-SELECTIN; LIPID A; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; MYELOID DIFFERENTIATION FACTOR 88; MYELOPOIESIS; NEUTROPHILS; RECEPTORS, INTERLEUKIN-8B; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 85002909118     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1A0216-072R     Document Type: Article

References (39)

1. Qureshi, N., Takayama, K., Ribi, E. (1982) Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium. J. Biol. Chem. 257, 11808–11815.
2. Bentala, H., Verweij, W. R., Huizinga-Vander Vlag, A., Van Loenen-Weemaes, A. M., Meijer, D. K., Poelstra, K. (2002) Removal of phosphate from lipid A as a strategy to detoxify lipopolysaccharide. Shock 18, 561–566.
3. Maiti, K. K., Decastro, M., El-Sayed, A. B. M. A. A., Foote, M. I., Wolfert, M. A., Boons, G. J. (2010) Chemical synthesis and proinflammatory responses of monophosphoryl lipid A adjuvant candidates. Eur. J. Org. Chem. 2010, 80–91.
4. Pichichero, M. E. (2008) Improving vaccine delivery using novel adjuvant systems. Hum. Vaccin. 4, 262–270.
5. Casella, C. R., Mitchell, T. C. (2008) Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell. Mol. Life Sci. 65, 3231–3240.
6. ZOE-50 Study Group. (2015) Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N. Engl. J. Med. 372, 2087–2096.
7. Evans, J. T., Cluff, C. W., Johnson, D. A., Lacy, M. J., Persing, D. H., Baldridge, J. R. (2003) Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529. Expert Rev. Vaccines 2, 219–229.
8. De Becker, G., Moulin, V., Pajak, B., Bruck, C., Francotte, M., Thiriart, C., Urbain, J., Moser, M. (2000) The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells. Int. Immunol. 12, 807–815.
9. De Veer, M., Kemp, J., Chatelier, J., Elhay, M. J., Meeusen, E. N. (2012) Modulation of soluble and particulate antigen transport in afferent lymph by monophosphoryl lipid A. Immunol. Cell Biol. 90, 404–410.
10. Martin, M., Michalek, S. M., Katz, J. (2003) Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A. Infect. Immun. 71, 2498–2507.
11. Baldridge, J. R., McGowan, P., Evans, J. T., Cluff, C., Mossman, S., Johnson, D., Persing, D. (2004) Taking a toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin. Biol. Ther. 4, 1129–1138.
12. Ogawa, T., Nakazawa, M., Masui, K. (1996) Immunopharmacological activities of the nontoxic monophosphoryl lipid A of Porphyromonas gingivalis. Vaccine 14, 70–76.
13. Masihi, K. N., Lange, W., Brehmer, W., Ribi, E. (1986) Immunobiological activities of nontoxic lipid A: enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects. Int. J. Immunopharmacol. 8, 339–345.
14. Masihi, K. N., Ribi, E., Lange, W., Werner, H. (1988) Effects of nontoxic lipid A and endotoxin on resistance of mice to Toxoplasma gondii. J. Biol. Response Mod. 7, 535–539.
15. Romero, C. D., Varma, T. K., Hobbs, J. B., Reyes, A., Driver, B., Sherwood, E. R. (2011) The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection. Infect. Immun. 79, 3576–3587.
16. Bohannon, J. K., Hernandez, A., Enkhbaatar, P., Adams, W. L., Sherwood, E. R. (2013) The immunobiology of toll-like receptor 4 agonists: fromendotoxin tolerance to immunoadjuvants. Shock 40, 451–462.
17. Bohannon, J. K., Luan, L., Hernandez, A., Afzal, A., Guo, Y., Patil, N. K., Fensterheim, B., Sherwood, E. R. (2015) Role of G-CSF in monophosphoryl lipid A-mediated augmentation of neutrophil functions after burn injury. J. Leukoc. Biol. 99, 629–640.
18. Gandhapudi, S. K., Chilton, P. M., Mitchell, T. C. (2013) TRIF is required for TLR4 mediated adjuvant effects on T cell clonal expansion. PLoS One 8, e56855.
19. Mata-Haro, V., Cekic, C., Martin, M., Chilton, P. M., Casella, C. R., Mitchell, T. C. (2007) The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR 4. Science 316, 1628–1632.
20. Kolanowski, S. T., Dieker, M. C., Lissenberg-Thunnissen, S. N., van Schijndel, G. M., van Ham, S. M., ten Brinke, A. (2014) TLR4-mediated pro-inflammatory dendritic cell differentiation in humans requires the combined action of MyD88 and TRIF. Innate Immun. 20, 423–430.
21. Kopp, E., Medzhitov, R. (2003) Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 15, 396–401.
22. Stockinger, S., Reutterer, B., Schaljo, B., Schellack, C., Brunner, S., Materna, T., Yamamoto, M., Akira, S., Taniguchi, T., Murray, P. J., Müller, M., Decker, T. (2004) IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2- independent mechanism. J. Immunol. 173, 7416–7425.
23. Sato, S., Sugiyama, M., Yamamoto, M., Watanabe, Y., Kawai, T., Takeda, K., Akira, S. (2003) Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J. Immunol. 171, 4304–4310.
24. Del Rio, L., Bennouna, S., Salinas, J., Denkers, E. Y. (2001) CXCR2 deficiency confers impaired neutrophil recruitment and increased susceptibility during Toxoplasma gondii infection. J. Immunol. 167, 6503–6509.
25. Wareing, M. D., Shea, A. L., Inglis, C. A., Dias, P. B., Sarawar, S. R. (2007) CXCR2 is required for neutrophil recruitment to the lung during influenza virus infection, but is not essential for viral clearance. Viral Immunol. 20, 369–378.
26. Stadtmann, A., Zarbock, A. (2012) CXCR2: from bench to bedside. Front. Immunol. 3, 263.
27. Ingersoll, M. A., Kline, K. A., Nielsen, H. V., Hultgren, S. J. (2008) G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity. Cell. Microbiol. 10, 2568–2578.
28. Metkar, S., Kim, K. S., Silver, J., Goyert, S. M. (2012) Differential expression of CD14-dependent and independent pathways for chemokine induction regulates neutrophil trafficking in infection. J. Leukoc. Biol. 92, 389–396.
29. Shi, X., Siggins, R. W., Stanford, W. L., Melvan, J. N., Basson, M. D., Zhang, P. (2013) Toll-like receptor 4/stem cell antigen 1 signaling promotes hematopoietic precursor cell commitment to granulocyte development during the granulopoietic response to Escherichia coli bacteremia. Infect. Immun. 81, 2197–2205.
30. Boettcher, S., Gerosa, R. C., Radpour, R., Bauer, J., Ampenberger, F., Heikenwalder, M., Kopf, M., Manz, M. G. (2014) Endothelial cells translate pathogen signals into G-CSF-driven emergency granulopoiesis. Blood 124, 1393–1403.
31. Manz, M. G., Boettcher, S. (2014) Emergency granulopoiesis. Nat. Rev. Immunol. 14, 302–314.
32. Liverani, E., Rico, M. C., Yaratha, L., Tsygankov, A. Y., Kilpatrick, L. E., Kunapuli, S. P. (2014) LPS-induced systemic inflammation is more severe in P2Y12 null mice. J. Leukoc. Biol. 95, 313–323.
33. Hu, X., Liu, R., Zhu, N. (2013) Enhancement of humoral and cellular immune responses by monophosphoryl lipid A (MPLA) as an adjuvant to the rabies vaccine in BALB/c mice. Immunobiology 218, 1524–1528.
34. Cuenca, A. G., Delano, M. J., Kelly-Scumpia, K. M., Moreno, C., Scumpia, P. O., Laface, D. M., Heyworth, P. G., Efron, P. A., Moldawer, L. L. (2011) A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol. Med. 17, 281–292.
35. Pico de Coaña, Y., Poschke, I., Gentilcore, G., Mao, Y., Nyström, M., Hansson, J., Masucci, G. V., Kiessling, R. (2013) Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid-derived suppressor cells as well as their Arginase1 production. Cancer Immunol. Res. 1, 158–162.
36. García-Vicuña, R., Díaz-González, F., González-Alvaro, I., del Pozo, M. A., Mollinedo, F., Cabañas, C., González-Amaro, R., Sánchez-Madrid, F. (1997) Prevention of cytokine-induced changes in leukocyte adhesion receptors by nonsteroidal antiinflammatory drugs from the oxicam family. Arthritis Rheum. 40, 143–153.
37. Schubert, N., Berthold, T., Muschter, S., Wesche, J., Fürll, B., Reil, A., Bux, J., Bakchoul, T., Greinacher, A. (2013) Human neutrophil antigen- 3a antibodies induce neutrophil aggregation in a plasma-free medium. Blood Transfus. 11, 541–547.
38. Rainer, T. H., Lam, N. Y., Chan, T. Y., Cocks, R. A. (2000) Early role of neutrophil L-selectin in posttraumatic acute lung injury. Crit. Care Med. 28, 2766–2772.
39. Paugam, C., Chollet-Martin, S., Dehoux, M., Chatel, D., Brient, N., Desmonts, J. M., Philip, I. (1997) Neutrophil expression of CD11b/CD18 and IL-8 secretion during normothermic cardiopulmonary bypass. J. Cardiothorac. Vasc. Anesth. 11, 575–579.